. UAE was inversely correlated with DLCO, DLCO/VA, DLCO/VA% and DLCO% (p=0.050; p=<0.001; p=0.001; p=0.004, respectively). Conclusion This study demonstrated that alveolar gas exchange capacity is significantly decreased in diabetic patients. Microalbuminuria may be one of the predictors of this decline.
Introduction

Diabetic micro and macrovascular complications are well identified and organ damage is generally thoroughly investigated in clinic follow-up. However, data concerning altered pulmonary diffusion as a sign of alveolar capillary damage are scarce. The development of diabetic complications might be explained by the biochemical alteration of connective tissue constituents, particularly collagen and elastin as well as microangiopathy due to a nonenzimatic glycosylation of proteins induced by chronic hyperglycemia (1, 2). Diabetic microangiopathy can involve alveolar tissue and capillaries, the largest microvascular bed in the body, leading to restriction of lung volume and alveolar gas transport, as manifested by reduced diffusing capacity of the lung for carbon monoxide (DLCO), as well as its components: membrane diffusing capacity and pulmonary capillary blood volume (3). In recent years it has been documented that alveolar epithelial and endothelial capillary basal lamina are significantly thicker in autopsied patients with diabetes mellitus than in the control subjects (4, 5). Any disorder causing a corruption in the integrity of alveolocapillary membranes of lungs which have an important modulatory role in alveolar gas exchange, may cause an abnormality in the CO diffusing capacity of lungs
. Recent studies offer solid support to the concept that albuminuria is a marker of endothelial dysfunction in the heart and kidneys (7) (8) (9) (10) .
This study has been designed to determine the association between microalbuminuria and the alteration of pulmonary diffusing capacity indicating alveolar capillary endothelial damage in diabetic patients. 
T a b l e 1 . Co mp a r i s o n o f t h e T wo Di a b e t i c S u b g r o u p s a n d t h e Co n t r o l Gr o u p
the participants by a turbidimetric inhibition immunoassay (Beckman nephelometry) (11). The mean values between 30-300 mg/24 hour were accepted as microalbuminuria. Diabetic individuals were separated into groups according to the presence of microalbuminuria.
Measurement of lung diffusion capacity
Diffusion capacity is defined as the volume of a gas (1 mL) (18) . This results with ultrastructural destruction at target organs (6, (18) (19) (20) . The abundant connective tissue and extensive microvascular circulation in lungs increase the probability of being a target organ in diabetic patients (6, 17) . Ofulue et al (21) (3) . Some others offer solid support to the concept that microalbuminuria is an indicator of ischemic heart disease as well as nephropathy (26, 27 
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